The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review

Domenico de Berardis*, Michele Fornaro, Laura Orsolini, Felice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis, Nicola Serroni, Alessandro Valchera, Alessandro Carano, Federica Vellante, Stefano Marini, Monica Piersanti, Giampaolo Perna, Giovanni Martinotti, Massimo Di Giannantonio

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number349
Number of pages15
JournalInternational journal of molecular sciences
Volume18
Issue number2
DOIs
Publication statusPublished - Feb 2017

Keywords

  • loxapine
  • inhaled
  • agitation
  • schizophrenia
  • bipolar disorder
  • antipsychotics
  • efficacy
  • tolerability
  • THERMALLY GENERATED AEROSOL
  • TYPICAL ANTIPSYCHOTIC-DRUGS
  • RAPID ACUTE TREATMENT
  • BIPOLAR DISORDER
  • PREFRONTAL CORTEX
  • IN-VITRO
  • HYDROXYLATED METABOLITES
  • STACCATO(R) LOXAPINE
  • HEALTHY-VOLUNTEERS
  • INHALATION POWDER

Cite this

de Berardis, D., Fornaro, M., Orsolini, L., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., Serroni, N., Valchera, A., Carano, A., Vellante, F., Marini, S., Piersanti, M., Perna, G., Martinotti, G., & Di Giannantonio, M. (2017). The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review. International journal of molecular sciences, 18(2), [349]. https://doi.org/10.3390/ijms18020349